🚀 VC round data is live in beta, check it out!

Scholar Rock Valuation Multiples

Discover revenue and EBITDA valuation multiples for Scholar Rock and similar public comparables like Alkermes, Gan and Lee, Xenon Pharmaceuticals, TG Therapeutics and more.

Scholar Rock Overview

About Scholar Rock

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.


Founded

2017

HQ

United States

Employees

196

Financials (LTM)

Revenue: $5M
EBITDA: ($379M)

EV

$5B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Scholar Rock Financials

Scholar Rock reported last 12-month revenue of $5M and negative EBITDA of ($379M).

In the same LTM period, Scholar Rock generated $5M in gross profit, ($379M) in EBITDA losses, and had net loss of ($376M).

Revenue (LTM)


Scholar Rock P&L

In the most recent fiscal year, Scholar Rock reported revenue of — and EBITDA of ($369M).

Scholar Rock expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Scholar Rock forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$5MXXX—XXXXXXXXX
Gross Profit$5MXXX—XXXXXXXXX
Gross Margin86%XXX—XXXXXXXXX
EBITDA($379M)XXX($369M)XXXXXXXXX
EBITDA Margin(7213%)XXX—XXXXXXXXX
EBIT Margin(7376%)XXX—XXXXXXXXX
Net Profit($376M)XXX($378M)XXXXXXXXX
Net Margin(7162%)XXX—XXXXXXXXX

Financial data powered by Morningstar, Inc.

Scholar Rock Stock Performance

Scholar Rock has current market cap of $6B, and enterprise value of $5B.

Market Cap Evolution


Scholar Rock's stock price is $49.96.

See Scholar Rock trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$6B0.1%XXXXXXXXX$-3.29

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Scholar Rock Valuation Multiples

Scholar Rock trades at 1043.0x EV/Revenue multiple, and (14.5x) EV/EBITDA.

See valuation multiples for Scholar Rock and 15K+ public comps

EV / Revenue (LTM)


Scholar Rock Financial Valuation Multiples

As of April 19, 2026, Scholar Rock has market cap of $6B and EV of $5B.

Equity research analysts estimate Scholar Rock's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Scholar Rock has a P/E ratio of (15.3x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$6BXXX$6BXXXXXXXXX
EV (current)$5BXXX$5BXXXXXXXXX
EV/Revenue1043.0xXXX—XXXXXXXXX
EV/EBITDA(14.5x)XXX(14.8x)XXXXXXXXX
EV/EBIT(14.1x)XXX(14.2x)XXXXXXXXX
EV/Gross Profit1216.9xXXX—XXXXXXXXX
P/E(15.3x)XXX(15.2x)XXXXXXXXX
EV/FCF(18.3x)XXX(18.2x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Scholar Rock Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Scholar Rock Margins & Growth Rates

Scholar Rock's revenue in the last 12 month grew by 1091%.

Scholar Rock's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $2.0M for the same period.

See operational valuation multiples for Scholar Rock and other 15K+ public comps

Scholar Rock Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth1091%XXX—XXXXXXXXX
EBITDA Margin(7213%)XXX—XXXXXXXXX
EBITDA Growth(11%)XXX(0%)XXXXXXXXX
Revenue per Employee—XXX$0.0MXXXXXXXXX
Opex per Employee—XXX$2.0MXXXXXXXXX
G&A Expenses to Revenue3423%XXX—XXXXXXXXX
R&D Expenses to Revenue3961%XXX—XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Scholar Rock Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Scholar RockXXXXXXXXXXXXXXXXXX
AlkermesXXXXXXXXXXXXXXXXXX
Gan and LeeXXXXXXXXXXXXXXXXXX
Xenon PharmaceuticalsXXXXXXXXXXXXXXXXXX
TG TherapeuticsXXXXXXXXXXXXXXXXXX
Henlius BiotechXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Scholar Rock M&A Activity

Scholar Rock acquired XXX companies to date.

Last acquisition by Scholar Rock was on XXXXXXXX, XXXXX. Scholar Rock acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Scholar Rock

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Scholar Rock Investment Activity

Scholar Rock invested in XXX companies to date.

Scholar Rock made its latest investment on XXXXXXXX, XXXXX. Scholar Rock invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Scholar Rock

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Scholar Rock

When was Scholar Rock founded?Scholar Rock was founded in 2017.
Where is Scholar Rock headquartered?Scholar Rock is headquartered in United States.
How many employees does Scholar Rock have?As of today, Scholar Rock has over 196 employees.
Who is the CEO of Scholar Rock?Scholar Rock's CEO is David L. Hallal.
Is Scholar Rock publicly listed?Yes, Scholar Rock is a public company listed on Nasdaq.
What is the stock symbol of Scholar Rock?Scholar Rock trades under SRRK ticker.
When did Scholar Rock go public?Scholar Rock went public in 2018.
Who are competitors of Scholar Rock?Scholar Rock main competitors are Alkermes, Gan and Lee, Xenon Pharmaceuticals, TG Therapeutics.
What is the current market cap of Scholar Rock?Scholar Rock's current market cap is $6B.
What is the current revenue of Scholar Rock?Scholar Rock's last 12 months revenue is $5M.
What is the current revenue growth of Scholar Rock?Scholar Rock revenue growth (NTM/LTM) is 1091%.
What is the current EV/Revenue multiple of Scholar Rock?Current revenue multiple of Scholar Rock is 1043.0x.
Is Scholar Rock profitable?No, Scholar Rock is not profitable.
What is the current EBITDA of Scholar Rock?Scholar Rock has negative EBITDA and is not profitable.
What is Scholar Rock's EBITDA margin?Scholar Rock's last 12 months EBITDA margin is (7213%).
What is the current EV/EBITDA multiple of Scholar Rock?Current EBITDA multiple of Scholar Rock is (14.5x).
What is the current FCF of Scholar Rock?Scholar Rock's last 12 months FCF is ($300M).
What is Scholar Rock's FCF margin?Scholar Rock's last 12 months FCF margin is (5711%).
What is the current EV/FCF multiple of Scholar Rock?Current FCF multiple of Scholar Rock is (18.3x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial